| Literature DB >> 10358032 |
X Sun1, J Lee, T Navas, D T Baldwin, T A Stewart, V M Dixit.
Abstract
RIP3 is a novel gene product containing a N-terminal kinase domain that shares extensive homology with the corresponding domain in RIP (receptor-interacting protein) and RIP2. Unlike RIP, which has a C-terminal death domain, and RIP2, which has a C-terminal caspase activation and recruitment domain, RIP3 has a unique C terminus. RIP3 binds RIP through its unique C-terminal segment and by virtue of this interaction is recruited to the tumor necrosis factor (TNF) receptor-1 signaling complex. Previous studies have shown that RIP mediates TNF-induced activation of the anti-apoptotic NF-kappaB pathway. RIP3, however, attenuates both RIP and TNF receptor-1-induced NF-kappaB activation. Overexpression studies revealed RIP3 to be a potent inducer of apoptosis, capable of selectively binding to large prodomain initiator caspases.Entities:
Mesh:
Substances:
Year: 1999 PMID: 10358032 DOI: 10.1074/jbc.274.24.16871
Source DB: PubMed Journal: J Biol Chem ISSN: 0021-9258 Impact factor: 5.157